Back to Search
Start Over
Aeterna the latest company to report trial delays brought on by Russia's war in Ukraine.
- Source :
- FierceBiotech; 3/21/2022, pN.PAG-N.PAG, 1p
- Publication Year :
- 2022
-
Abstract
- Aeterna Zentaris has had to push recruitment plans for a phase 3 trial of a diagnostic test in children into 2023 due to delays brought on by Russia's war in Ukraine. [ABSTRACT FROM AUTHOR]
- Subjects :
- CORPORATION reports
CRIME & the press
CLINICAL trials
DIAGNOSIS methods
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 156291567